Park Ha Biological Technology BYAH
NASDAQ BYAH
$2.27 -0.04 (-1.73%)
At close: Oct 1, 2026 · 4:00 PM EDT

Park Ha Biological Technology (BYAH) Current Deferred Revenue (2023 - 2026)

Updated

Park Ha Biological Technology (BYAH) recorded Current Deferred Revenue of $194,968 in fiscal Q2 2026 (quarter ended Apr 30, 2026), up 64.8% from $118,277 a year earlier.

Analysis

Park Ha Biological Technology (BYAH) Current Deferred Revenue (2023 - 2026) Analysis & Trends

At the end of FY2025 (ended Oct 31, 2025), Park Ha Biological Technology reported Current Deferred Revenue of $194,753, down 40.2% from FY2024.

  • Across earlier fiscal years, Current Deferred Revenue came in at $325,924 in FY2024 (+30.1%) and $250,549 in FY2023.
  • The fiscal Q2 2026 figure is the highest quarterly Current Deferred Revenue since fiscal Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Procter & Gamble 337.81 Bn 293.80 Bn 10.28 Bn
2 Colgate Palmolive 68.01 Bn 63.06 Bn 3.30 Bn
3 Kenvue 33.93 Bn 29.54 Bn 2.30 Bn
4 Estee Lauder Companies 33.63 Bn 21.70 Bn 2.74 Bn
5 Kimberly Clark 32.41 Bn 29.73 Bn 1.60 Bn
6 Church & Dwight 22.35 Bn 20.88 Bn 693.90 Mn
7 Clorox 9.80 Bn 8.24 Bn 804.00 Mn
8 e.l.f. Beauty 5.95 Bn 4.92 Bn 398.84 Mn
9 Reynolds Consumer Products 4.56 Bn 4.22 Bn 245.00 Mn
10 Park Ha Biological Technology 195,624.66 -11.15 Mn -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 194,968.00
Oct 31, 2025 194,753.00
Apr 30, 2025 118,277.00
Oct 31, 2024 325,924.00
Oct 31, 2023 250,549.00
API Access

Park Ha Biological Technology Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BYAH&period=max&api_key=YOUR_API_KEY